Delivery Order SPE2DB24D2101-SPE2DB25FKLHW

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $13,259.50 and has a period of performance through March 4, 2025. The contract is for the supply of the pharmaceutical product SCEMBLIX 40 MG TABLET, which is likely used for various medical treatments. This delivery order contract is associated with...
This federal contract award, valued at $24,304.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug product SCEMBLIX 40 MG TABLET. It is a firm-fixed-price contract with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,259.50 fixed-price contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a specialty medication. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $13,259.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET medication, with a performance period through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $13,259.50. The award is for the pharmaceutical product SCEMBLIX 40 MG TABLET UU 60S, with a performance period ending on May 23, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a $26,519.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568461040 - SCEMBLIX 40 MG TABLET UU 60S, a prescription medication, with a completion date of June 27, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,519.00, is a delivery order for the medication SCEMBLIX 40 MG TABLET, with a performance period extending through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and has no listed...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract has a ceiling value of $13,259.50 and is a firm fixed-price delivery order. The place of performance is Conshohocken, Pennsylvania. The contract is not set-aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,637.88 firm fixed-price delivery order is for the supply of 60 tablets of SCEMBLIX 20 MG, a pharmaceutical product. The award has an ultimate completion date of January 24, 2025 and was made on January 2, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLHW
    Delivery Order

This is a $39,778.50 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order contract is associated with that larger IDC vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract is not designated as a set-aside, indicating open competition. As a prime contractor, AmerisourceBergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/10/25, 9:49 AM